MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

William A. Hyman

William A. Hyman is a professor emeritus in the department of biomedical engineering at Texas A&M University and adjunct professor of biomedical engineering at the Cooper Union. Reach him at [email protected].

William’s Recent activity

CQOE and Funky Math
CQOE and Funky Math
Apr 10, 2018
What type of score will your company earn under FDA's Pre-Cert Program for Software as a Medical Device (SaMD)?
Applying Risk Strategies to Implantable Devices
Feb 23, 2011
Risk evaluation and mitigation strategy (REMS) is a regulatory technique implemented by FDA to ensure that the benefits of a specific drug outweigh its associated risks. Before REMS was developed, FDA recommended that...
Risk Analysis: Beyond Probability and Severity
Aug 05, 2010
Although a combination of probability and severity is commonly used for estimating risk, it can be useful to consider other factors that may also affect whether a risk is deemed acceptable.